# Keith Newton

> Keith Newton is Concentra’s chief executive officer and a director, based in McKinney, Texas. An accounting graduate of Texas A&M University, he joined predecessor OccuSystems in 1995, left in 2011, and returned as CEO in 2015. He led Concentra through its 2024 NYSE listing and separation from Select Medical and is scheduled to become executive chairman on November 1, 2026.

- **Role:** Chief Executive Officer at Concentra
- **Organizations:** Concentra, OccuSystems, DentalOne Partners, Columbia HCA, Medical Care International, The Associates First Capital Corporation, KPMG Peat Marwick, Texas A&M University
- **Education:** Bachelor of Business Administration in Accounting, Texas A&M University
- **Known for:** Led Concentra through its July 2024 NYSE listing., Led Concentra during the November 2024 completion of its spin-off from Select Medical., Returned as CEO in 2015 after an earlier tenure as president and COO.

## Career timeline

- **1985** — Earned a BBA in accounting from Texas A&M University.
- **Before 1991** — Worked as a CPA at KPMG Peat Marwick and in accounting and finance roles at The Associates First Capital Corporation.
- **1991-1995** — Worked at Medical Care International and Columbia HCA’s Ambulatory Surgery Division.
- **1995** — Joined OccuSystems, a predecessor of Concentra.
- **1997** — OccuSystems participated in the merger that formed Concentra.
- **1999-2007** — Served as president of Concentra’s former Health Services division.
- **2007-2011** — Served as Concentra president and chief operating officer.
- **2011-2015** — Held senior leadership roles at DentalOne Partners.
- **2015-06** — Returned to Concentra as president and chief executive officer.
- **2018-2022** — Also served as chairman during Concentra’s joint-venture ownership.
- **2023** — Concluded his tenure as Concentra president while continuing as CEO.
- **2024-07** — Led Concentra through its NYSE listing under CON.
- **2024-11** — Concentra completed its spin-off from Select Medical.
- **2026-11** — Scheduled to become executive chairman on November 1, with Matt DiCanio succeeding him as CEO.

## Achievements

- Led Concentra through its July 2024 NYSE listing.
- Led Concentra during the November 2024 completion of its spin-off from Select Medical.
- Returned as CEO in 2015 after an earlier tenure as president and COO.

## Latest updates

- **2026-08** — Concentra announced that Newton will transition from CEO to executive chairman, effective November 1, 2026, as part of a multiyear succession plan.
- **2026-09** — Concentra announced Tanner Newton’s appointment as CFO effective November 1, completing another step in the previously announced succession process.

## Links

- Website: https://www.concentra.com/
- LinkedIn: https://www.linkedin.com/in/keith-newton-b5543010

---

Profile page: https://yespress.io/keith-newton
Published by YesPress — https://yespress.io
Last updated: 2026-10-22